Current issues in pharmacy and medicine science and practice, Journal Year: 2023, Volume and Issue: 16(3), P. 205 - 212
Published: Nov. 3, 2023
Pain represents a primary symptom of numerous diseases and conditions, affecting millions people worldwide. Effective analgesic medications can alleviate or eliminate pain, thereby enhancing patients’ quality life assisting them in resuming normal physical social activities. However, several existing analgesics may carry unwanted side effects, such as ulcers, blood clotting issues, drowsiness, more. The development new is focused on creating drugs that are both effective associated with fewer adverse effects. Considering the continuous rise number patients dealing neurological, oncological, other conditions accompanied by chronic there growing demand for innovative methods treatment pain management. combination two different heterocyclic fragments within one molecule makes it possible to use possibilities influencing various mechanisms occurrence pathological including those pain. Chemical modifications pyrazole 1,2,4-triazole structures, involving their incorporation into single molecule, have potential, suggested silico predictions, yield biologically active compounds properties. aim this work was determine optimal chemical transformation properties 4-amino-5-(3-methylpyrazol-5-yl)-1,2,4-triazole-3-thiol, 4-amino-5-(3-(3-fluorophenyl)pyrazol-5-yl)-1,2,4-triazole-3-thiol derivatives preparation bioactive systems activity. Materials methods. creation target series implemented consistently using well-known organic synthesis. 4-Amino-5-(3-methylpyrazole-5-yl)-1,2,4-triazole-3-thiol 4-amino-5-(3-(3-fluorophenyl)pyrazole-5-yl)-1,2,4-triazole-3-thiol were resynthesized starting materials acetone 1-(3-fluorophenyl)ethane-1-one, diethyloxalate, sodium methylate step-by-step hydrazinolysis carbon disulfide involvement an alkaline medium. Further targeted functionalization involved introduction 2,6-dichlorophenyl substitute, alkane acid residues, esters based structure compounds. all synthesized substances determined IR spectrophotometry, 1H NMR spectroscopy, elemental analysis. individuality confirmed high-performance liquid chromatography-mass spectrometry. studied models: “acetic acid-induced writhing test” formalin model inflammation. Pharmacokinetic parameters predictably calculated SwissADME online platform. Results. Based results synthetic part work, 4-amino-5-(3-methylpyrazole-5-yl)-1,2,4-triazole-3-thiol 4-amino-5-(3-(3-fluorophenyl)pyrazole-5-yl)-1,2,4-triazole-3-thiol, well derivatives, successfully recreated. presence beneficial effect saturated carboxylic acids formation antinociceptive activity has been proven. quantitative indicators pharmacokinetic parameters, during ADME analysis, fall acceptable ranges nearly instances. Conclusions. synthesis structural modification established, which allowed 2-((4-amino-5-(3-methylpyrazol-5-yl)-1,2,4-triazol-3-yl)thio)alkanoic esters, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazine systems. It shown 1,2,4-triazol-3-thiol substituent creates activity, vivo experimental data acetic test inflammation model.
Language: Английский